Indivior Pharmaceuticals Inc
INDV
Kedudukan dalam Saham
#3840
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Harga Saham
$34.93
Modal Pasaran
$4.36B
Perubahan (1 hari)
3.11%
Perubahan (1 tahun)
43.78%
Negara
US
Perdagangan Indivior Pharmaceuticals Inc (INDV)
Kategori
Healthcare
Hasil untuk Indivior Pharmaceuticals Inc (INDV)
Hasil pada Jun 2026 TTM: $1.33B
Menurut laporan kewangan terkini daripada Indivior Pharmaceuticals Inc, hasil semasa syarikat (TTM) ialah $1.33B. Pada tahun 2023, syarikat memperoleh hasil sebanyak $1.09B peningkatan berbanding hasil pada tahun 2022 iaitu $901.00M. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Indivior Pharmaceuticals Inc dari 2016 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $1.33B | 12.12% |
| 2024 | $1.19B | 8.69% |
| 2023 | $1.09B | 21.31% |
| 2022 | $901.00M | 13.91% |
| 2021 | $791.00M | 22.26% |
| 2020 | $647.00M | -17.58% |
| 2019 | $785.00M | -18.22% |
| 2018 | $959.92M | -16.39% |
| 2017 | $1.15B | 18.50% |
| 2016 | $968.89M | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 396.37% |
IN
|
